Agnieszka Marczak

University of Łódź

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Krzysztof Szczepanowicz

Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences

POLAND

View details

Piotr Krzeczyński

Chief Specialist

Łukasiewicz Research Network - Industrial Chemistry Institute

POLAND

View details

Aneta Rogalska

associate professor/PhD, DSc

Lodz University of Technology

POLAND

View details

Krzysztof Walczak

Head of Department/Professor

Silesian University of Technology

POLAND

View details

Agnieszka Sliwinska

Head/ Associate Professor

Medical University of Lodz

POLAND

View details

Maksim Ionov

Professor

Lodz University of Technology

POLAND

View details

Damian Kołat

Medical University of Lodz

POLAND

View details

Udo Gaipl

Head of Radiation Immunobiology

Universitätsklinikum Erlangen

GERMANY

View details

Sylwia Michlewska

Lodz University of Technology

POLAND

View details

Dorota Rybaczek

Associate Professor

Lodz University of Technology

POLAND

View details

Radoslaw Kitel

Jagiellonian University

POLAND

View details

Grzegorz Dzido

Silesian University of Technology

POLAND

View details

Michal Mikula

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Marta Szczech

Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Agnieszka Marczak

Research Interests

Explore related searches

Contact this professor

Articles (13)

Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer

Uncovering miRNA–mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors

Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment—The Current State of Knowledge

New SDS-Based Polyelectrolyte Multicore Nanocarriers for Paclitaxel Delivery—Synthesis, Characterization, and Activity against Breast Cancer Cells

Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival

The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCAMUT and BRCAWT Ovarian Cancer Cells

Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells

Hexokinase 2 Inhibition and Biological Effects of BNBZ and Its Derivatives: The Influence of the Number and Arrangement of Hydroxyl Groups

Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells

PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines

Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer

Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches

Collaborators (14)

Krzysztof Szczepanowicz

Piotr Krzeczyński

Aneta Rogalska

Krzysztof Walczak

Agnieszka Sliwinska

Maksim Ionov

Damian Kołat

Udo Gaipl

Sylwia Michlewska

Dorota Rybaczek

Radoslaw Kitel

Grzegorz Dzido

Michal Mikula

Marta Szczech

Make your next move.